Global Buerger's Disease Treatment Market Growth 2025-2031--LP INFORMATION, INC.

Global Buerger's Disease Treatment Market Growth 2025-2031

Product Code: 1468668

Industry: Pharma & Healthcare

Published: Apr 10,2025

Pages: 95

Delivery Time: 2-3 business days

Global Buerger's Disease Treatment Market Growth 2025-2031

Product Code: 1468668

Industry: Pharma & Healthcare

Published: Apr 10,2025

Pages: 95

Delivery Time: 2-3 business days

Select A Format

Single User License

USD3660

Multi Users License

USD5490

Corporate Users License

USD7320

Buy Now

Add To Cart

Or More Options：

PDF Download

Sample Request

Custom Request

Provide market analysis and obtain sources of data reports

Description

The global Buerger's Disease Treatment market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

Berger"s disease occurs mostly in young and middle-aged men, and most of them have a history of heavy smoking. Typical manifestations are intermittent claudication, rest pain, and migratory thrombophlebitis. The disease mainly invades the limbs, especially the medium and small arteries of the lower limbs and their accompanying veins and superficial skin veins. The affected blood vessels present non-suppurative inflammation of the whole thickness of the vessel wall, and there is thrombosis in the lumen, which is progressive. Stenosis or even complete occlusion can cause limb ischemia and pain. In severe cases, ulcers and gangrene that are not easy to heal may occur in the limbs.

United States market for Buerger's Disease Treatment is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Buerger's Disease Treatment is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Buerger's Disease Treatment is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Buerger's Disease Treatment players cover FUJIFILM Holdings Corporation, General Electric, Koninklijke Philips NV, Pluristem Inc, Shimadzu Corporation, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Buerger's Disease Treatment Industry Forecast” looks at past sales and reviews total world Buerger's Disease Treatment sales in 2024, providing a comprehensive analysis by region and market sector of projected Buerger's Disease Treatment sales for 2025 through 2031. With Buerger's Disease Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Buerger's Disease Treatment industry.

This Insight Report provides a comprehensive analysis of the global Buerger's Disease Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Buerger's Disease Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Buerger's Disease Treatment market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Buerger's Disease Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Buerger's Disease Treatment.

This report presents a comprehensive overview, market shares, and growth opportunities of Buerger's Disease Treatment market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

    Vasodilators

    Prostaglandins

    Other

Segmentation by Application:

    Hospitals

    Specialty Clinics

    Other

This report also splits the market by region:

    Americas

    United States

    Canada

    Mexico

    Brazil

    APAC

    China

    Japan

    Korea

    Southeast Asia

    India

    Australia

    Europe

    Germany

    France

UK

    Italy

    Russia

    Middle East & Africa

    Egypt

    South Africa

    Israel

    Turkey

    GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

    FUJIFILM Holdings Corporation

    General Electric

    Koninklijke Philips NV

    Pluristem Inc

    Shimadzu Corporation

    Siemens Healthcare GmbH

    STEMPEUTICS RESEARCH PVT LTD

    Toshiba Medical Corporation

Key Questions Addressed in this Report

What is the 10-year outlook for the global Buerger's Disease Treatment market?

What factors are driving Buerger's Disease Treatment market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Buerger's Disease Treatment market opportunities vary by end market size?

How does Buerger's Disease Treatment break out by Type, by Application?

Table Of Contents

1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
    1.8 Market Estimation Caveats

2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Buerger's Disease Treatment Annual Sales 2020-2031
        2.1.2 World Current & Future Analysis for Buerger's Disease Treatment by Geographic Region, 2020, 2024 & 2031
        2.1.3 World Current & Future Analysis for Buerger's Disease Treatment by Country/Region, 2020, 2024 & 2031
    2.2 Buerger's Disease Treatment Segment by Type
        2.2.1 Vasodilators
        2.2.2 Prostaglandins
        2.2.3 Other
    2.3 Buerger's Disease Treatment Sales by Type
        2.3.1 Global Buerger's Disease Treatment Sales Market Share by Type (2020-2025)
        2.3.2 Global Buerger's Disease Treatment Revenue and Market Share by Type (2020-2025)
        2.3.3 Global Buerger's Disease Treatment Sale Price by Type (2020-2025)
    2.4 Buerger's Disease Treatment Segment by Application
        2.4.1 Hospitals
        2.4.2 Specialty Clinics
        2.4.3 Other
    2.5 Buerger's Disease Treatment Sales by Application
        2.5.1 Global Buerger's Disease Treatment Sale Market Share by Application (2020-2025)
        2.5.2 Global Buerger's Disease Treatment Revenue and Market Share by Application (2020-2025)
        2.5.3 Global Buerger's Disease Treatment Sale Price by Application (2020-2025)

3 Global by Company
    3.1 Global Buerger's Disease Treatment Breakdown Data by Company
        3.1.1 Global Buerger's Disease Treatment Annual Sales by Company (2020-2025)
        3.1.2 Global Buerger's Disease Treatment Sales Market Share by Company (2020-2025)
    3.2 Global Buerger's Disease Treatment Annual Revenue by Company (2020-2025)
        3.2.1 Global Buerger's Disease Treatment Revenue by Company (2020-2025)
        3.2.2 Global Buerger's Disease Treatment Revenue Market Share by Company (2020-2025)
    3.3 Global Buerger's Disease Treatment Sale Price by Company
    3.4 Key Manufacturers Buerger's Disease Treatment Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers Buerger's Disease Treatment Product Location Distribution
        3.4.2 Players Buerger's Disease Treatment Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
    3.6 New Products and Potential Entrants
    3.7 Market M&A Activity & Strategy

4 World Historic Review for Buerger's Disease Treatment by Geographic Region
    4.1 World Historic Buerger's Disease Treatment Market Size by Geographic Region (2020-2025)
        4.1.1 Global Buerger's Disease Treatment Annual Sales by Geographic Region (2020-2025)
        4.1.2 Global Buerger's Disease Treatment Annual Revenue by Geographic Region (2020-2025)
    4.2 World Historic Buerger's Disease Treatment Market Size by Country/Region (2020-2025)
        4.2.1 Global Buerger's Disease Treatment Annual Sales by Country/Region (2020-2025)
        4.2.2 Global Buerger's Disease Treatment Annual Revenue by Country/Region (2020-2025)
    4.3 Americas Buerger's Disease Treatment Sales Growth
    4.4 APAC Buerger's Disease Treatment Sales Growth
    4.5 Europe Buerger's Disease Treatment Sales Growth
    4.6 Middle East & Africa Buerger's Disease Treatment Sales Growth

5 Americas
    5.1 Americas Buerger's Disease Treatment Sales by Country
        5.1.1 Americas Buerger's Disease Treatment Sales by Country (2020-2025)
        5.1.2 Americas Buerger's Disease Treatment Revenue by Country (2020-2025)
    5.2 Americas Buerger's Disease Treatment Sales by Type (2020-2025)
    5.3 Americas Buerger's Disease Treatment Sales by Application (2020-2025)
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil

6 APAC
    6.1 APAC Buerger's Disease Treatment Sales by Region
        6.1.1 APAC Buerger's Disease Treatment Sales by Region (2020-2025)
        6.1.2 APAC Buerger's Disease Treatment Revenue by Region (2020-2025)
    6.2 APAC Buerger's Disease Treatment Sales by Type (2020-2025)
    6.3 APAC Buerger's Disease Treatment Sales by Application (2020-2025)
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 China Taiwan

7 Europe
    7.1 Europe Buerger's Disease Treatment by Country
        7.1.1 Europe Buerger's Disease Treatment Sales by Country (2020-2025)
        7.1.2 Europe Buerger's Disease Treatment Revenue by Country (2020-2025)
    7.2 Europe Buerger's Disease Treatment Sales by Type (2020-2025)
    7.3 Europe Buerger's Disease Treatment Sales by Application (2020-2025)
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia

8 Middle East & Africa
    8.1 Middle East & Africa Buerger's Disease Treatment by Country
        8.1.1 Middle East & Africa Buerger's Disease Treatment Sales by Country (2020-2025)
        8.1.2 Middle East & Africa Buerger's Disease Treatment Revenue by Country (2020-2025)
    8.2 Middle East & Africa Buerger's Disease Treatment Sales by Type (2020-2025)
    8.3 Middle East & Africa Buerger's Disease Treatment Sales by Application (2020-2025)
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries

9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends

10 Manufacturing Cost Structure Analysis
    10.1 Raw Material and Suppliers
    10.2 Manufacturing Cost Structure Analysis of Buerger's Disease Treatment
    10.3 Manufacturing Process Analysis of Buerger's Disease Treatment
    10.4 Industry Chain Structure of Buerger's Disease Treatment

11 Marketing, Distributors and Customer
    11.1 Sales Channel
        11.1.1 Direct Channels
        11.1.2 Indirect Channels
    11.2 Buerger's Disease Treatment Distributors
    11.3 Buerger's Disease Treatment Customer

12 World Forecast Review for Buerger's Disease Treatment by Geographic Region
    12.1 Global Buerger's Disease Treatment Market Size Forecast by Region
        12.1.1 Global Buerger's Disease Treatment Forecast by Region (2026-2031)
        12.1.2 Global Buerger's Disease Treatment Annual Revenue Forecast by Region (2026-2031)
    12.2 Americas Forecast by Country (2026-2031)
    12.3 APAC Forecast by Region (2026-2031)
    12.4 Europe Forecast by Country (2026-2031)
    12.5 Middle East & Africa Forecast by Country (2026-2031)
    12.6 Global Buerger's Disease Treatment Forecast by Type (2026-2031)
    12.7 Global Buerger's Disease Treatment Forecast by Application (2026-2031)

13 Key Players Analysis
    13.1 FUJIFILM Holdings Corporation
        13.1.1 FUJIFILM Holdings Corporation Company Information
        13.1.2 FUJIFILM Holdings Corporation Buerger's Disease Treatment Product Portfolios and Specifications
        13.1.3 FUJIFILM Holdings Corporation Buerger's Disease Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
        13.1.4 FUJIFILM Holdings Corporation Main Business Overview
        13.1.5 FUJIFILM Holdings Corporation Latest Developments
    13.2 General Electric
        13.2.1 General Electric Company Information
        13.2.2 General Electric Buerger's Disease Treatment Product Portfolios and Specifications
        13.2.3 General Electric Buerger's Disease Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
        13.2.4 General Electric Main Business Overview
        13.2.5 General Electric Latest Developments
    13.3 Koninklijke Philips NV
        13.3.1 Koninklijke Philips NV Company Information
        13.3.2 Koninklijke Philips NV Buerger's Disease Treatment Product Portfolios and Specifications
        13.3.3 Koninklijke Philips NV Buerger's Disease Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
        13.3.4 Koninklijke Philips NV Main Business Overview
        13.3.5 Koninklijke Philips NV Latest Developments
    13.4 Pluristem Inc
        13.4.1 Pluristem Inc Company Information
        13.4.2 Pluristem Inc Buerger's Disease Treatment Product Portfolios and Specifications
        13.4.3 Pluristem Inc Buerger's Disease Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
        13.4.4 Pluristem Inc Main Business Overview
        13.4.5 Pluristem Inc Latest Developments
    13.5 Shimadzu Corporation
        13.5.1 Shimadzu Corporation Company Information
        13.5.2 Shimadzu Corporation Buerger's Disease Treatment Product Portfolios and Specifications
        13.5.3 Shimadzu Corporation Buerger's Disease Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
        13.5.4 Shimadzu Corporation Main Business Overview
        13.5.5 Shimadzu Corporation Latest Developments
    13.6 Siemens Healthcare GmbH
        13.6.1 Siemens Healthcare GmbH Company Information
        13.6.2 Siemens Healthcare GmbH Buerger's Disease Treatment Product Portfolios and Specifications
        13.6.3 Siemens Healthcare GmbH Buerger's Disease Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
        13.6.4 Siemens Healthcare GmbH Main Business Overview
        13.6.5 Siemens Healthcare GmbH Latest Developments
    13.7 STEMPEUTICS RESEARCH PVT LTD
        13.7.1 STEMPEUTICS RESEARCH PVT LTD Company Information
        13.7.2 STEMPEUTICS RESEARCH PVT LTD Buerger's Disease Treatment Product Portfolios and Specifications
        13.7.3 STEMPEUTICS RESEARCH PVT LTD Buerger's Disease Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
        13.7.4 STEMPEUTICS RESEARCH PVT LTD Main Business Overview
        13.7.5 STEMPEUTICS RESEARCH PVT LTD Latest Developments
    13.8 Toshiba Medical Corporation
        13.8.1 Toshiba Medical Corporation Company Information
        13.8.2 Toshiba Medical Corporation Buerger's Disease Treatment Product Portfolios and Specifications
        13.8.3 Toshiba Medical Corporation Buerger's Disease Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
        13.8.4 Toshiba Medical Corporation Main Business Overview
        13.8.5 Toshiba Medical Corporation Latest Developments

14 Research Findings and Conclusion

List Of Tables

List of Tables
 Table 1. Buerger's Disease Treatment Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
 Table 2. Buerger's Disease Treatment Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
 Table 3. Major Players of Vasodilators
 Table 4. Major Players of Prostaglandins
 Table 5. Major Players of Other
 Table 6. Global Buerger's Disease Treatment Sales by Type (2020-2025) & (K Units)
 Table 7. Global Buerger's Disease Treatment Sales Market Share by Type (2020-2025)
 Table 8. Global Buerger's Disease Treatment Revenue by Type (2020-2025) & ($ million)
 Table 9. Global Buerger's Disease Treatment Revenue Market Share by Type (2020-2025)
 Table 10. Global Buerger's Disease Treatment Sale Price by Type (2020-2025) & (US$/Unit)
 Table 11. Global Buerger's Disease Treatment Sale by Application (2020-2025) & (K Units)
 Table 12. Global Buerger's Disease Treatment Sale Market Share by Application (2020-2025)
 Table 13. Global Buerger's Disease Treatment Revenue by Application (2020-2025) & ($ million)
 Table 14. Global Buerger's Disease Treatment Revenue Market Share by Application (2020-2025)
 Table 15. Global Buerger's Disease Treatment Sale Price by Application (2020-2025) & (US$/Unit)
 Table 16. Global Buerger's Disease Treatment Sales by Company (2020-2025) & (K Units)
 Table 17. Global Buerger's Disease Treatment Sales Market Share by Company (2020-2025)
 Table 18. Global Buerger's Disease Treatment Revenue by Company (2020-2025) & ($ millions)
 Table 19. Global Buerger's Disease Treatment Revenue Market Share by Company (2020-2025)
 Table 20. Global Buerger's Disease Treatment Sale Price by Company (2020-2025) & (US$/Unit)
 Table 21. Key Manufacturers Buerger's Disease Treatment Producing Area Distribution and Sales Area
 Table 22. Players Buerger's Disease Treatment Products Offered
 Table 23. Buerger's Disease Treatment Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
 Table 24. New Products and Potential Entrants
 Table 25. Market M&A Activity & Strategy
 Table 26. Global Buerger's Disease Treatment Sales by Geographic Region (2020-2025) & (K Units)
 Table 27. Global Buerger's Disease Treatment Sales Market Share Geographic Region (2020-2025)
 Table 28. Global Buerger's Disease Treatment Revenue by Geographic Region (2020-2025) & ($ millions)
 Table 29. Global Buerger's Disease Treatment Revenue Market Share by Geographic Region (2020-2025)
 Table 30. Global Buerger's Disease Treatment Sales by Country/Region (2020-2025) & (K Units)
 Table 31. Global Buerger's Disease Treatment Sales Market Share by Country/Region (2020-2025)
 Table 32. Global Buerger's Disease Treatment Revenue by Country/Region (2020-2025) & ($ millions)
 Table 33. Global Buerger's Disease Treatment Revenue Market Share by Country/Region (2020-2025)
 Table 34. Americas Buerger's Disease Treatment Sales by Country (2020-2025) & (K Units)
 Table 35. Americas Buerger's Disease Treatment Sales Market Share by Country (2020-2025)
 Table 36. Americas Buerger's Disease Treatment Revenue by Country (2020-2025) & ($ millions)
 Table 37. Americas Buerger's Disease Treatment Sales by Type (2020-2025) & (K Units)
 Table 38. Americas Buerger's Disease Treatment Sales by Application (2020-2025) & (K Units)
 Table 39. APAC Buerger's Disease Treatment Sales by Region (2020-2025) & (K Units)
 Table 40. APAC Buerger's Disease Treatment Sales Market Share by Region (2020-2025)
 Table 41. APAC Buerger's Disease Treatment Revenue by Region (2020-2025) & ($ millions)
 Table 42. APAC Buerger's Disease Treatment Sales by Type (2020-2025) & (K Units)
 Table 43. APAC Buerger's Disease Treatment Sales by Application (2020-2025) & (K Units)
 Table 44. Europe Buerger's Disease Treatment Sales by Country (2020-2025) & (K Units)
 Table 45. Europe Buerger's Disease Treatment Revenue by Country (2020-2025) & ($ millions)
 Table 46. Europe Buerger's Disease Treatment Sales by Type (2020-2025) & (K Units)
 Table 47. Europe Buerger's Disease Treatment Sales by Application (2020-2025) & (K Units)
 Table 48. Middle East & Africa Buerger's Disease Treatment Sales by Country (2020-2025) & (K Units)
 Table 49. Middle East & Africa Buerger's Disease Treatment Revenue Market Share by Country (2020-2025)
 Table 50. Middle East & Africa Buerger's Disease Treatment Sales by Type (2020-2025) & (K Units)
 Table 51. Middle East & Africa Buerger's Disease Treatment Sales by Application (2020-2025) & (K Units)
 Table 52. Key Market Drivers & Growth Opportunities of Buerger's Disease Treatment
 Table 53. Key Market Challenges & Risks of Buerger's Disease Treatment
 Table 54. Key Industry Trends of Buerger's Disease Treatment
 Table 55. Buerger's Disease Treatment Raw Material
 Table 56. Key Suppliers of Raw Materials
 Table 57. Buerger's Disease Treatment Distributors List
 Table 58. Buerger's Disease Treatment Customer List
 Table 59. Global Buerger's Disease Treatment Sales Forecast by Region (2026-2031) & (K Units)
 Table 60. Global Buerger's Disease Treatment Revenue Forecast by Region (2026-2031) & ($ millions)
 Table 61. Americas Buerger's Disease Treatment Sales Forecast by Country (2026-2031) & (K Units)
 Table 62. Americas Buerger's Disease Treatment Annual Revenue Forecast by Country (2026-2031) & ($ millions)
 Table 63. APAC Buerger's Disease Treatment Sales Forecast by Region (2026-2031) & (K Units)
 Table 64. APAC Buerger's Disease Treatment Annual Revenue Forecast by Region (2026-2031) & ($ millions)
 Table 65. Europe Buerger's Disease Treatment Sales Forecast by Country (2026-2031) & (K Units)
 Table 66. Europe Buerger's Disease Treatment Revenue Forecast by Country (2026-2031) & ($ millions)
 Table 67. Middle East & Africa Buerger's Disease Treatment Sales Forecast by Country (2026-2031) & (K Units)
 Table 68. Middle East & Africa Buerger's Disease Treatment Revenue Forecast by Country (2026-2031) & ($ millions)
 Table 69. Global Buerger's Disease Treatment Sales Forecast by Type (2026-2031) & (K Units)
 Table 70. Global Buerger's Disease Treatment Revenue Forecast by Type (2026-2031) & ($ millions)
 Table 71. Global Buerger's Disease Treatment Sales Forecast by Application (2026-2031) & (K Units)
 Table 72. Global Buerger's Disease Treatment Revenue Forecast by Application (2026-2031) & ($ millions)
 Table 73. FUJIFILM Holdings Corporation Basic Information, Buerger's Disease Treatment Manufacturing Base, Sales Area and Its Competitors
 Table 74. FUJIFILM Holdings Corporation Buerger's Disease Treatment Product Portfolios and Specifications
 Table 75. FUJIFILM Holdings Corporation Buerger's Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 76. FUJIFILM Holdings Corporation Main Business
 Table 77. FUJIFILM Holdings Corporation Latest Developments
 Table 78. General Electric Basic Information, Buerger's Disease Treatment Manufacturing Base, Sales Area and Its Competitors
 Table 79. General Electric Buerger's Disease Treatment Product Portfolios and Specifications
 Table 80. General Electric Buerger's Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 81. General Electric Main Business
 Table 82. General Electric Latest Developments
 Table 83. Koninklijke Philips NV Basic Information, Buerger's Disease Treatment Manufacturing Base, Sales Area and Its Competitors
 Table 84. Koninklijke Philips NV Buerger's Disease Treatment Product Portfolios and Specifications
 Table 85. Koninklijke Philips NV Buerger's Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 86. Koninklijke Philips NV Main Business
 Table 87. Koninklijke Philips NV Latest Developments
 Table 88. Pluristem Inc Basic Information, Buerger's Disease Treatment Manufacturing Base, Sales Area and Its Competitors
 Table 89. Pluristem Inc Buerger's Disease Treatment Product Portfolios and Specifications
 Table 90. Pluristem Inc Buerger's Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 91. Pluristem Inc Main Business
 Table 92. Pluristem Inc Latest Developments
 Table 93. Shimadzu Corporation Basic Information, Buerger's Disease Treatment Manufacturing Base, Sales Area and Its Competitors
 Table 94. Shimadzu Corporation Buerger's Disease Treatment Product Portfolios and Specifications
 Table 95. Shimadzu Corporation Buerger's Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 96. Shimadzu Corporation Main Business
 Table 97. Shimadzu Corporation Latest Developments
 Table 98. Siemens Healthcare GmbH Basic Information, Buerger's Disease Treatment Manufacturing Base, Sales Area and Its Competitors
 Table 99. Siemens Healthcare GmbH Buerger's Disease Treatment Product Portfolios and Specifications
 Table 100. Siemens Healthcare GmbH Buerger's Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 101. Siemens Healthcare GmbH Main Business
 Table 102. Siemens Healthcare GmbH Latest Developments
 Table 103. STEMPEUTICS RESEARCH PVT LTD Basic Information, Buerger's Disease Treatment Manufacturing Base, Sales Area and Its Competitors
 Table 104. STEMPEUTICS RESEARCH PVT LTD Buerger's Disease Treatment Product Portfolios and Specifications
 Table 105. STEMPEUTICS RESEARCH PVT LTD Buerger's Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 106. STEMPEUTICS RESEARCH PVT LTD Main Business
 Table 107. STEMPEUTICS RESEARCH PVT LTD Latest Developments
 Table 108. Toshiba Medical Corporation Basic Information, Buerger's Disease Treatment Manufacturing Base, Sales Area and Its Competitors
 Table 109. Toshiba Medical Corporation Buerger's Disease Treatment Product Portfolios and Specifications
 Table 110. Toshiba Medical Corporation Buerger's Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 111. Toshiba Medical Corporation Main Business
 Table 112. Toshiba Medical Corporation Latest Developments


List of Figures
 Figure 1. Picture of Buerger's Disease Treatment
 Figure 2. Buerger's Disease Treatment Report Years Considered
 Figure 3. Research Objectives
 Figure 4. Research Methodology
 Figure 5. Research Process and Data Source
 Figure 6. Global Buerger's Disease Treatment Sales Growth Rate 2020-2031 (K Units)
 Figure 7. Global Buerger's Disease Treatment Revenue Growth Rate 2020-2031 ($ millions)
 Figure 8. Buerger's Disease Treatment Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
 Figure 9. Buerger's Disease Treatment Sales Market Share by Country/Region (2024)
 Figure 10. Buerger's Disease Treatment Sales Market Share by Country/Region (2020, 2024 & 2031)
 Figure 11. Product Picture of Vasodilators
 Figure 12. Product Picture of Prostaglandins
 Figure 13. Product Picture of Other
 Figure 14. Global Buerger's Disease Treatment Sales Market Share by Type in 2025
 Figure 15. Global Buerger's Disease Treatment Revenue Market Share by Type (2020-2025)
 Figure 16. Buerger's Disease Treatment Consumed in Hospitals
 Figure 17. Global Buerger's Disease Treatment Market: Hospitals (2020-2025) & (K Units)
 Figure 18. Buerger's Disease Treatment Consumed in Specialty Clinics
 Figure 19. Global Buerger's Disease Treatment Market: Specialty Clinics (2020-2025) & (K Units)
 Figure 20. Buerger's Disease Treatment Consumed in Other
 Figure 21. Global Buerger's Disease Treatment Market: Other (2020-2025) & (K Units)
 Figure 22. Global Buerger's Disease Treatment Sale Market Share by Application (2024)
 Figure 23. Global Buerger's Disease Treatment Revenue Market Share by Application in 2025
 Figure 24. Buerger's Disease Treatment Sales by Company in 2025 (K Units)
 Figure 25. Global Buerger's Disease Treatment Sales Market Share by Company in 2025
 Figure 26. Buerger's Disease Treatment Revenue by Company in 2025 ($ millions)
 Figure 27. Global Buerger's Disease Treatment Revenue Market Share by Company in 2025
 Figure 28. Global Buerger's Disease Treatment Sales Market Share by Geographic Region (2020-2025)
 Figure 29. Global Buerger's Disease Treatment Revenue Market Share by Geographic Region in 2025
 Figure 30. Americas Buerger's Disease Treatment Sales 2020-2025 (K Units)
 Figure 31. Americas Buerger's Disease Treatment Revenue 2020-2025 ($ millions)
 Figure 32. APAC Buerger's Disease Treatment Sales 2020-2025 (K Units)
 Figure 33. APAC Buerger's Disease Treatment Revenue 2020-2025 ($ millions)
 Figure 34. Europe Buerger's Disease Treatment Sales 2020-2025 (K Units)
 Figure 35. Europe Buerger's Disease Treatment Revenue 2020-2025 ($ millions)
 Figure 36. Middle East & Africa Buerger's Disease Treatment Sales 2020-2025 (K Units)
 Figure 37. Middle East & Africa Buerger's Disease Treatment Revenue 2020-2025 ($ millions)
 Figure 38. Americas Buerger's Disease Treatment Sales Market Share by Country in 2025
 Figure 39. Americas Buerger's Disease Treatment Revenue Market Share by Country (2020-2025)
 Figure 40. Americas Buerger's Disease Treatment Sales Market Share by Type (2020-2025)
 Figure 41. Americas Buerger's Disease Treatment Sales Market Share by Application (2020-2025)
 Figure 42. United States Buerger's Disease Treatment Revenue Growth 2020-2025 ($ millions)
 Figure 43. Canada Buerger's Disease Treatment Revenue Growth 2020-2025 ($ millions)
 Figure 44. Mexico Buerger's Disease Treatment Revenue Growth 2020-2025 ($ millions)
 Figure 45. Brazil Buerger's Disease Treatment Revenue Growth 2020-2025 ($ millions)
 Figure 46. APAC Buerger's Disease Treatment Sales Market Share by Region in 2025
 Figure 47. APAC Buerger's Disease Treatment Revenue Market Share by Region (2020-2025)
 Figure 48. APAC Buerger's Disease Treatment Sales Market Share by Type (2020-2025)
 Figure 49. APAC Buerger's Disease Treatment Sales Market Share by Application (2020-2025)
 Figure 50. China Buerger's Disease Treatment Revenue Growth 2020-2025 ($ millions)
 Figure 51. Japan Buerger's Disease Treatment Revenue Growth 2020-2025 ($ millions)
 Figure 52. South Korea Buerger's Disease Treatment Revenue Growth 2020-2025 ($ millions)
 Figure 53. Southeast Asia Buerger's Disease Treatment Revenue Growth 2020-2025 ($ millions)
 Figure 54. India Buerger's Disease Treatment Revenue Growth 2020-2025 ($ millions)
 Figure 55. Australia Buerger's Disease Treatment Revenue Growth 2020-2025 ($ millions)
 Figure 56. China Taiwan Buerger's Disease Treatment Revenue Growth 2020-2025 ($ millions)
 Figure 57. Europe Buerger's Disease Treatment Sales Market Share by Country in 2025
 Figure 58. Europe Buerger's Disease Treatment Revenue Market Share by Country (2020-2025)
 Figure 59. Europe Buerger's Disease Treatment Sales Market Share by Type (2020-2025)
 Figure 60. Europe Buerger's Disease Treatment Sales Market Share by Application (2020-2025)
 Figure 61. Germany Buerger's Disease Treatment Revenue Growth 2020-2025 ($ millions)
 Figure 62. France Buerger's Disease Treatment Revenue Growth 2020-2025 ($ millions)
 Figure 63. UK Buerger's Disease Treatment Revenue Growth 2020-2025 ($ millions)
 Figure 64. Italy Buerger's Disease Treatment Revenue Growth 2020-2025 ($ millions)
 Figure 65. Russia Buerger's Disease Treatment Revenue Growth 2020-2025 ($ millions)
 Figure 66. Middle East & Africa Buerger's Disease Treatment Sales Market Share by Country (2020-2025)
 Figure 67. Middle East & Africa Buerger's Disease Treatment Sales Market Share by Type (2020-2025)
 Figure 68. Middle East & Africa Buerger's Disease Treatment Sales Market Share by Application (2020-2025)
 Figure 69. Egypt Buerger's Disease Treatment Revenue Growth 2020-2025 ($ millions)
 Figure 70. South Africa Buerger's Disease Treatment Revenue Growth 2020-2025 ($ millions)
 Figure 71. Israel Buerger's Disease Treatment Revenue Growth 2020-2025 ($ millions)
 Figure 72. Turkey Buerger's Disease Treatment Revenue Growth 2020-2025 ($ millions)
 Figure 73. GCC Countries Buerger's Disease Treatment Revenue Growth 2020-2025 ($ millions)
 Figure 74. Manufacturing Cost Structure Analysis of Buerger's Disease Treatment in 2025
 Figure 75. Manufacturing Process Analysis of Buerger's Disease Treatment
 Figure 76. Industry Chain Structure of Buerger's Disease Treatment
 Figure 77. Channels of Distribution
 Figure 78. Global Buerger's Disease Treatment Sales Market Forecast by Region (2026-2031)
 Figure 79. Global Buerger's Disease Treatment Revenue Market Share Forecast by Region (2026-2031)
 Figure 80. Global Buerger's Disease Treatment Sales Market Share Forecast by Type (2026-2031)
 Figure 81. Global Buerger's Disease Treatment Revenue Market Share Forecast by Type (2026-2031)
 Figure 82. Global Buerger's Disease Treatment Sales Market Share Forecast by Application (2026-2031)
 Figure 83. Global Buerger's Disease Treatment Revenue Market Share Forecast by Application (2026-2031)

Companies Mentioned

FUJIFILM Holdings Corporation

General Electric

Koninklijke Philips NV

Pluristem Inc

Shimadzu Corporation

Siemens Healthcare GmbH

STEMPEUTICS RESEARCH PVT LTD

Toshiba Medical Corporation

Methodology

LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

Data Sourse

Primary Source

Secondary Source

Players/Suppliers

Journals and Periodicals

Industry Experts

Government Bodies

Distributors/Traders

Annual Reports

Opinion Leaders

Presentations

Front-line Staff